Table 3.

The Sensitivity of Lymphatic Metastasis of Colorectal Cancer Assayed by CSE1L and CEA

Groups	Lymph node metastasis (n = 42)*	Distant metastasis (n = 9)†	Lymph node or distant metastasis (n = 51)
CSE1L-positive, cases (%)	30 (71.4)‡	8 (88.9)¶	38 (74.5)**
CEA-positive, cases (%)	20 (47.6)	7 (77.8)	27 (52.9)
CSE1L or CEA-positive, cases (%)	37 (88.1)§	9 (100)∥	46 (90.2)††

^*Lymph node metastasis: N0M0, N1M0, and N2M0. 

^†Distant metastasis: N0M1, N1M1, and N2M1. 

^‡P = 0.0009, compared with that of CEA-positive cases in the lymphatic metastasis group. 

^§P = 0.000004, compared with that of CEA-positive cases in the lymphatic metastasis group. 

^¶P = 0.346, compared with that of CEA-positive cases in the distant metastasis group. 

^∥P = 0.169, compared with that of CEA-positive cases in the distant metastasis group. 

^**P = 0.0005, compared with that of CEA-positive cases in the lymph node or distant metastasis group. 

^††P < 0.0001, compared with that of CEA-positive cases in the lymph node or distant metastasis group.